Annual Current Liabilities
$93.17 M
-$7.09 M-7.08%
December 31, 2023
Summary
- As of February 7, 2025, RXRX annual total current liabilities is $93.17 million, with the most recent change of -$7.09 million (-7.08%) on December 31, 2023.
- During the last 3 years, RXRX annual current liabilities has risen by +$70.07 million (+303.36%).
- RXRX annual current liabilities is now -7.08% below its all-time high of $100.27 million, reached on December 31, 2022.
Performance
RXRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$108.89 M
+$22.80 M+26.49%
September 30, 2024
Summary
- As of February 7, 2025, RXRX quarterly total current liabilities is $108.89 million, with the most recent change of +$22.80 million (+26.49%) on September 30, 2024.
- Over the past year, RXRX quarterly current liabilities has increased by +$34.97 million (+47.31%).
- RXRX quarterly current liabilities is now -4.45% below its all-time high of $113.96 million, reached on June 30, 2023.
Performance
RXRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RXRX Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -7.1% | +47.3% |
3 y3 years | +303.4% | +8.6% |
5 y5 years | +1293.9% | +8.6% |
RXRX Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -7.1% | +99.7% | -4.5% | +133.4% |
5 y | 5-year | -7.1% | +1293.9% | -4.5% | +371.4% |
alltime | all time | -7.1% | +1293.9% | -4.5% | +371.4% |
Recursion Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $108.89 M(+26.5%) |
Jun 2024 | - | $86.08 M(+16.5%) |
Mar 2024 | - | $73.92 M(-20.7%) |
Dec 2023 | $93.17 M(-7.1%) | $93.17 M(-1.0%) |
Sep 2023 | - | $94.12 M(-17.4%) |
Jun 2023 | - | $113.96 M(+23.7%) |
Mar 2023 | - | $92.15 M(-8.1%) |
Dec 2022 | $100.27 M | $100.27 M(+20.7%) |
Sep 2022 | - | $83.04 M(-14.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $96.65 M(+12.8%) |
Mar 2022 | - | $85.70 M(+83.7%) |
Dec 2021 | $46.66 M(+102.0%) | $46.66 M(+8.7%) |
Sep 2021 | - | $42.94 M(+45.4%) |
Jun 2021 | - | $29.54 M(+10.0%) |
Mar 2021 | - | $26.85 M(+16.3%) |
Dec 2020 | $23.10 M(+245.6%) | - |
Dec 2020 | - | $23.10 M |
Dec 2019 | $6.68 M | - |
FAQ
- What is Recursion Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual current liabilities year-on-year change?
- What is Recursion Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly current liabilities year-on-year change?
What is Recursion Pharmaceuticals annual total current liabilities?
The current annual current liabilities of RXRX is $93.17 M
What is the all time high annual current liabilities for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total current liabilities is $100.27 M
What is Recursion Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, RXRX annual total current liabilities has changed by -$7.09 M (-7.08%)
What is Recursion Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of RXRX is $108.89 M
What is the all time high quarterly current liabilities for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total current liabilities is $113.96 M
What is Recursion Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, RXRX quarterly total current liabilities has changed by +$34.97 M (+47.31%)